A Prospective Screening of HLA-B*57.01 Allelic Variant for Preventing the Hypersensivity Reaction to Abacavir: Experience from the Laboratory of Molecular Biology of the Infectious Diseases Division at the University Hospital of Salerno

Abacavir is a nucleoside reverse transcriptase inhibitor largely used as part of the antiretroviral therapy in Human Immunodeficiency Virus (HIV)-infected patients. Some individuals (2–9%) who start an abacavir treatment show an immunologic reaction indicated as hypersensitivity reaction syndrome (H...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transl Med UniSa
Prif Awduron: Senatore, C, Charlier, B, Truono, A, Punzi, R, D’Aniello, F, Boffa, N, Izzo, V, Conti, V, Russomanno, G, Manzo, V, Filippelli, A, Mazzeo, M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Universitài Salerno 2014
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4309657/
https://ncbi.nlm.nih.gov/pubmed/25674551
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg